DeepIntent’s Patient Modeled Audiences Solution Uses Industry’s Most Comprehensive Real-World Clinical Datasets to Precisely Reach Patient Populations, Including Those Facing Rare Diseases and Low …
NEW YORK, Dec. 13, 2021 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, …
NEW YORK, Oct. 27, 2021 — DeepIntent, the leading independent healthcare marketing technology company built purposefully to influence patient health and business outcomes, today …
NEW YORK, Oct. 11, 2021 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, …
The release marks the industry’s first and only healthcare-specific data marketplace with ready-to-activate and custom audience segments NEW YORK, Sept. 27, 2021 — DeepIntent, …
With patented technology, the DeepIntent® Demand Side Platform is the first and only proven Demand Side Platform to drive up to 35%* higher script …
Industry’s First Demand-Side Platform Integrated With Real-World Clinical Data to Increase Script Lift, Improving Business Outcomes for Healthcare Marketers Beta leading pharmaceutical brand experienced …
Demonstrates gap between patients and providers about treatment options NEW YORK, March 25, 2021 – DeepIntent, the leading healthcare marketing technology company built purposefully …
